UnitedHealthcare’s 2027 Medicare Advantage lineup leans into $0 primary and preventive care, aiming to broaden access

UnitedHealth’s insurance arm, UnitedHealthcare, laid out its Medicare Advantage direction for 2027 in an early October 2026 announcement that emphasizes lower out-of-pocket costs for beneficiaries and smoother benefit access through the company’s UCard tool. The company’s pitch, as reported in a market recap, centers on a plan lineup that includes $0 primary and preventive care, along with coverage that the company said spans a broad set of geographies.

Medicare Advantage, for context, is the private version of Medicare in which beneficiaries typically receive their coverage through plans offered by companies like UnitedHealthcare. These plans are marketed locally, and enrollment decisions can turn on both pricing and the ease with which patients can use benefits for everyday medical needs such as doctor visits and routine prevention.

In the 2027 lineup, UnitedHealthcare highlighted $0 primary and preventive care as a core feature. Under typical Medicare Advantage benefit structures, “$0” generally refers to member cost at the point of care for specified services, though the exact service categories and rules can vary by plan and provider network. The announcement also pointed to an expanded footprint, describing the 2027 offering as having broad geographic reach.

UnitedHealthcare also said it is updating its UCard program. The UCard is an access and authorization mechanism designed to simplify how members use certain plan benefits, particularly at the point of care. In practical terms, features like the UCard can reduce friction by streamlining information exchange during visits, which can matter for member experience and for how consistently benefits are applied.

For UnitedHealth and its investors, the company’s Medicare Advantage choices are often read as indicates about its strategy for balancing growth and economics. Medicare Advantage is a large driver of revenue for UnitedHealth’s insurance segment, and the competitiveness of plan designs, member engagement tools, and service access can affect both enrollment demand and medical utilization patterns.

The company’s approach in the 2027 lineup appears to focus on two levers that are frequently discussed in Medicare Advantage competition: upfront member affordability for common care and operational simplicity for how benefits are accessed. By pairing $0 primary and preventive services with an updated UCard experience, UnitedHealthcare is essentially trying to make routine care easier to initiate and complete, which could support retention and referrals, even though the announcement did not provide specific utilization or retention metrics.

Still, key details were not provided in the reported recap. The announcement summary did not spell out pricing for other benefit categories beyond primary and preventive care, describe how plan designs vary by county or state, or quantify expected impacts on medical costs, margins, or member growth. It also did not disclose whether these changes are intended to address specific regulatory or reimbursement dynamics, or how UnitedHealthcare expects competitors to respond.

What to watch next is how the 2027 plan choices are finalized and implemented across the company’s service areas, including any additional benefit and network details that often emerge closer to enrollment periods. Investors and beneficiaries will also likely focus on whether the updated UCard experience changes how consistently members can access covered services, and whether UnitedHealthcare’s plan messaging translates into measurable enrollment momentum as the market looks toward 2027.